title: The management of residual or recurrent central neurocytoma.
abstract: Treatment following neurosurgical resection or biopsy of a central neurocytoma depends on the pathologic analysis and proliferative activity demonstrated, the extent of surgical resection, the neuroanatomic location and accessibility of residual tumor, and the patient's postoperative condition. The risks and benefits of additional surgery, radiation therapy, and/or chemotherapy should be weighed and individualized based on these factors and guided by the existing literature.
authors.affiliation: Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, 3 Silverstein Building, 3400 Spruce Street, Philadelphia, PA 19104, USA.
authors.forename: Jayesh P
authors.initials: JP
authors.lastname: Thawani
authors.affiliation: Department of Neurosurgery, Pennsylvania Hospital, Perelman School of Medicine at the University of Pennsylvania, Washington Square West Building, 235 South 8th Street, Philadelphia, PA 19106, USA. Electronic address: john.lee3@uphs.upenn.edu.
authors.forename: John Y K
authors.initials: JY
authors.lastname: Lee
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy / Q000601:surgery*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy / Q000601:surgery*; D018306:Neurocytoma / Q000532:radiotherapy / Q000601:surgery*
keywords: Central neurocytoma neurosurgery; Central neurocytoma radiotherapy; Mixed glial-neuronal tumor; Recurrent central neurocytoma; Residual central neurocytoma